Williams Paul Christopher bought CTKB
March 6, 2024 · Form 4 insider transaction
Williams Paul Christopher bought 210,526 shares of Cytek Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
210,526
Price
$0.00
Total value
N/A
InsiderWilliams Paul Christopher
RoleOfficer
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 6, 2024
Filing dateMarch 8, 2024
Shares owned after210,526
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest over 4 years with 1/48 of the total shares underlying the option vesting on April 6, 2024 and each month thereafter.